Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

XRHealth and HTC Introduce The First Distraction Therapy Virtual Reality Platform to Improve Patient Experience During Painful or Anxiety Provoking Medical Procedures

XRHealth, the leading healthcare metaverse platform, and HTC VIVE, the global leader in premium virtual reality (VR),  announced a new distraction therapy virtual reality platform  to improve the patient experience during painful or anxiety provoking medical procedures. The new solution combines XRHealth software with HTC’s VIVE Flow glasses and is designed to distract patients and alleviate pain and anxiety while undergoing challenging medical procedures like chemotherapy, surgery, MRIs, and receiving insulin or the painful process of giving birth, burn trauma, and many others.

Virtual reality distraction therapy transports the patient to a virtual world and guides them through meditation and other exercises that imbue the patient with skills to minimize pain and anxiety. Just recently PLOS One published a XRHealth platform  study based on clinical trials that demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth’ s immersive virtual reality software and done by Beth Israel Deaconess Medical Center physicians. In the study, distracting the patient’s mind from the procedure with virtual reality therapy, without compromising on the patient experience, proved to be successful and reduced the risk of over sedation.

Recommended AI News: HUB International Embeds Auto Insurance into Wayne Reaves Auto Dealer Management Software

“Distraction therapy enables the patient to have a positive experience during painful medical procedures without being over sedated with extraneous medication that sometimes creates a longer recovery process,” says Eran Orr, Chief Executive Officer of XRHealth. “The immersive and virtual environment removes patients from the pain of the current experience and transports them into a digital world that provides comfort and relief.”

The VIVE Flow form factor offers lightweight portability providing comfort and ease for patients to use the glasses during multiple types of medical procedures. The XRHealth software enables treating clinicians to view what patients are experiencing and communicate with them without breaking the digital immersive experience. The distraction therapy solution provides seamless patient set up and easy integration with hospitals and clinics.

Related Posts
1 of 33,650

Recommended AI News: New Slack Innovations and Salesforce Customer 360 Integrations Unlock Team Productivity, Adding Value to the Digital HQ

“VIVE Flow was designed to be comfortable and lightweight, which lets the hardware fade into the background so people can fully immerse in the magic of VR,” said Cher Wang, Co-Founder and Chairwoman at HTC. “Paired with XR Health’s groundbreaking platform, we’re on the cusp of a new era of effective and convenient VR treatments that offer support for patients to manage pain, anxiety, and more.”

The XRHealth software is FDA and CE registered and is used in hospitals worldwide including at Sheba Medical Center, the VA St. Louis Healthcare System, and many more. Clinicians can control, see, and receive real-time data updates while patients are using the software so that users can be monitored at all times during procedures.

Recommended AI News: Wiha Tools USA Adopts New Salsify Connector to Amazon A+ API

[To share your insights with us, please write to]

Comments are closed.